Maze Therapeutics Growth Metrics (2024-2026) | MAZE

Growth Metrics Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin (QoQ) (Quarter) -189953.0098,865.00
EBIT Margin (QoQ) (Quarter) -189953.0098,865.00
EBT Margin (QoQ) (Quarter) -193979.00102,082.00
Enterprise Value Growth (1y) (Quarter) -880.49%-51.11%-156.63%-73.73%-19.71%
Enterprise Value (QoQ) (Quarter) -483.10%14.54%-31.55%-49.57%10.13%-45.13%10.94%-3.06%
FCF Margin (QoQ) (Quarter) -190387.0095,058.00
Interest Coverage Ratio Growth (1y) (Quarter) -0.73%
Interest Coverage Ratio (QoQ) (Quarter) 2,185.96%
Net Margin (QoQ) (Quarter) -191628.00101,522.00
Operating Margin (QoQ) (Quarter) -189953.0098,865.00
Return on Assets Growth (1y) (Quarter) 0.00
Return on Assets (QoQ) (Quarter) -1.000.000.000.00
Return on Capital Employed Growth (1y) (Quarter) -5335.00
Return on Capital Employed (QoQ) (Quarter) -6091.00269.00258.00230.00
Return on Sales Growth (1y) (Quarter) -8.0011.00-1.00
Return on Sales (QoQ) (Quarter) -19.0010.00-1.001.000.00